Advertisement
Screener

PAR PHARMACEUTICAL COMPANIES, INC. Amortization of Intangible Assets

PAR PHARMACEUTICAL COMPANIES, INC. Amortization of Intangible Assets

PAR PHARMACEUTICAL COMPANIES, INC. reported Amortization of Intangible Assets of $84.50 million for the 6-month period ending 2015-06-30, per its 10-Q filed 2015-08-06.

Discontinued › Expense Statement › Operating Expenses

us-gaap:AmortizationOfIntangibleAssets · last filed 2015-08-06

  • PAR PHARMACEUTICAL COMPANIES, INC. amortization of intangible assets for the quarter ending 2015-06-30 was $36.10M, a 7.67% decline year-over-year.
  • PAR PHARMACEUTICAL COMPANIES, INC. amortization of intangible assets for the quarter ending 2015-03-31 was $48.40M, a 9.75% increase year-over-year.
  • PAR PHARMACEUTICAL COMPANIES, INC. amortization of intangible assets for the quarter ending 2014-09-30 was $38.15M, a 29.63% decline year-over-year.
  • PAR PHARMACEUTICAL COMPANIES, INC. amortization of intangible assets for the quarter ending 2014-06-30 was $39.10M, a 5.70% decline year-over-year.
Period endAmortization of Intangible Assets 3 monthAmortization of Intangible Assets 3 month as first filedAmortization of Intangible Assets 6 monthAmortization of Intangible Assets 6 month as first filedAmortization of Intangible Assets 9 month
2015-06-30$36.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
$84.50M
10-Q · filed 2015-08-06
2015-03-31$48.40M
10-Q · filed 2015-05-11
2014-09-30$38.15M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12
$77.25M
derived: sum of 2 quarters · filed 2015-08-06
$121.35M
10-Q · filed 2014-11-12
2014-06-30$39.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
$83.20M
10-Q · filed 2015-08-06
$83.16M
10-Q · filed 2014-08-11
2014-03-31$44.10M
10-Q · filed 2015-05-11
$44.10M
10-Q · filed 2014-05-15
2013-09-30$54.21M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12
$95.67M
derived: sum of 2 quarters · filed 2014-11-12
$135.74M
10-Q · filed 2014-11-12
2013-06-30$41.47M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11
$81.54M
10-Q · filed 2014-08-11
2013-03-31$40.07M
10-Q · filed 2014-05-15